Growth factors stimulate neointimal cells in vitro and increase the thickness of the neointima formed at the neck of porcine aneurysms treated by embolization

Stroke

Volumn 31, Issue 2, 2000, Pages 498-507

  Desfaits, Anne Cécile ^a   Raymond, Jean ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Cerebral aneurysm; Growth factors; Pathology

Indexed keywords

GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; CELL PROLIFERATION; DNA SYNTHESIS; HISTOPATHOLOGY; IN VITRO STUDY; INTIMA; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOSIS;

EID: 0033972831     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.2.498     Document Type: Article

References (70)

1. Raymond J, Roy D. Safety and efficacy of endovascular treatment of acutely ruptured aneurysms. Neurosurgery. 1997;41:1235-1245.
2. Vinuela F, Duckwiler G, Mawad M. Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J Neurosurg. 1997;86:475-482.
3. Raymond J, Venne D, Alias S, Roy D, Oliva VL, Salazkin I, Leclerc G. Healing mechanisms in experimental aneurysms treated by embolization, I: vascular smooth muscle cells and neointima formation. J Neuroradiol. 1999;26:7-20.
4. Venne D, Raymond J, Alias S, Roy D, Leclerc G, Boushira M, Brazeau P. Healing of experimental aneurysms. II: platelet extracts can increase the thickness of the neointima at the neck of treated aneurysms. J Neuroradiol. 1999;26:92-100.
5. Raymond J, Desfaits AC, Roy D. Fibrinogen and vascular smooth muscle cell grafts promote healing of experimental aneurysms treated by embolization. Stroke. 1999;30:1657-1664.
6. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
7. Jawien A, Bowen-Pope DF, Lindner V, Schwanz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimai thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
8. West JL, Hubbell JA. Separation of the arterial wall from blood contact using hydrogel barriers reduces intimai thickening after balloon injury in the rat: the role of medial and luminal factors in arterial healing. Proc Natl Acad Sci USA. 1996;93:13188-13193.
9. Newby AC, George SJ. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc Res 1993;27:1173-1183.
10. Reidy MA. Growth factors and arterial smooth muscle cell proliferation. Ann N Y Acad Sci. 1994;714:225-230.
11. Ross R. The pathogenesis of atherosclerosis: a perspective of the 1990s. Nature. 1993;362:801-809.
12. Schwartz SM, deBlois D, O'Brian ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
13. Waltenberger J. Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation. 1997;96: 4083-4094.
14. Evanko SP, Raines EW, Ross R, Gold LI, Wight TN. Proteoglycan distribution in lesions of atherosclerosis depends on lesion seventy, structural characteristics, and the proximity of platelet-derived growth factor and transformation growth factor-β. Am J Pathol. 1998;152: 533-546.
15. Nabel EG, Shum L, Pompili VJ, Yang Z-Y, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Nail Acad Sci USA. 1993;90:10759-10763.
16. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimai hyperplasia in vivo. J Clin Invest. 1993;91:1822-1829.
17. Majesky MW, Giachelli CM, Reidy MA, Schwanz SM. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 1992;71: 759-768.
18. Ueda M, Becker AE, Kasayuki N, Kojima A, Morila Y, Tanaka S. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am J Pathol. 1996;149:831-843.
19. German WJ, Black SPW. Experimental production of carotid aneurysms. N Engl J Med. 1954;250:104-106.
20. Hadrava V, Tremblay J, Hamet P. Abnormalities in growth characteristics of aortic smooth muscle cells from hypertensive and normotensive rats. Hypertension. 1989;13:589-597.
21. 3H-proline-labeled protein by rapid filtration in multiwell plates for the study of collagen metabolism. Biotechniques. 1997;22:706-716.
22. Byrne JV, Hope JKA, Hubbard N, Morris JH. The nature of thrombosis induced by platinum and tungsten coils in saccular aneurysms. AJNR Am J Neuroradiol. 1997;18:29-33.
23. Graves VB, Strother CM, Rappe AH. Treatment of experimental canine carotid aneurysms with platinum coils. AJNR Am J Neuroradiol. 1993;14:787-793.
24. Mawad ME, Mawad JK, Cartwright J, Gokasian Z. Long-term histopathologic changes in canine aneurysms embolized with Guglielmi detachable coils. AJNR Am J Neuroradiol. 1995;16:7-13.
25. Reul J, Weis J, Spetzger U, Konert T, Fricke C, Thron A. Long-term angiographic and histopathologic findings in experimental aneurysms of the carotid bifurcation embolized with platinum and tungsten coils. AJNR Am J Neuroradiol. 1997;18:35-42.
26. Murayama Y, Vinuela F, Suzuki Y, Do HM, Massoud TF, Guglielmi G, Ji C, Iwaki M, Kusakabe M, Kamio M, Abe T. Ion implantation and protein coating of detachable coils for endovascular treatment of cerebral aneurysms: concepts and preliminary results in swine models. Neurosurgery. 1997;40:1233-1244.
27. Tenjin H, Fushiki S, Nakahara Y, Masaki H, Matsuo T, Johnson CM, Ueda S. Effect of Guglielmi detachable coils on experimental carotid artery aneurysms in primates. Stroke. 1995;26:2075-2080.
28. Molyneux AJ, Ellison DW, Morris J, Byrne JV. Histological findings in giant aneurysms treated with Guglielmi detachable coils: report of two cases with autopsy correlation. J Neurosurg. 1995;83:129-132.
29. Manabe H, Fujita S, Hatayama T, Suzuki S, Yagihashi S, Rerupture of coil-embolized aneurysm during long-term observation: case report. J Neurosurg. 1998;88:1096-1098.
30. Bavinzski G, Talazoglu V, Killer M, Richling B, Gruber A, Gross CE, Plenk H. Gross and microscopic histopaihological findings in aneurysms of the human brain treated with Guglielmi detachable coils. J Neurosurg. 1999;91:284-293.
31. Schwartz RS, Edwards WD, Bailey KR, Camrud AR, Jorgenson MA, Holmes DR, Differential neointimal response to coronary artery injury in pigs and dogs. Arterioscler Thromb. 1994;14:395-400.
32. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:1284-1294.
33. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655-1664.
34. Seidel CL. Cellular heterogeneity of the vascular tunica media: implications for vessel wall repair. Anerioscler Thromb Vasc Biol. 1977; 17:1868-1871.
35. Zakewski A, Shi Y. Vascular myofibroblasts: lesions from coronary repair and remodeling. Arterioscler Thromb Vasc Biol. 1997;17: 417-422.
36. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological and immunohistochemical analyses. Circulation. 1998: 98:224-233.
37. Andreeva ER, Pugach IM, Orekhov AN. Subendolhelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. Atherosclerosis. 1997;135:19-27.
38. Shi Q, Wu MH-D, Hayashida N, Wechezak AR, Clowes AW, Sauvage LR. Proof of fallout endothelialization of impervious dacron grafts in the aorta and inferior vena cava of the dog. J Vasc Surg. 1994;20: 546-557.
39. Feigl W, Susani M, Ulrich W, Matejka M, Losert U, Sinzinger H. Organisation of experimental thrombosis by blood cells. Virchows Arch (Pathol Ana). 1985;406:133-148.
40. Tanizawa S, Ueda M, van der Loos CM, van der Wal AC, Becker AE. Expression of platelet derived growth factor B chain and βreceptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study. Heart. 1996;549-556.
41. Chamley-Campbell JH, Campbell GR, Ross R. Phenotype-dependem response of cultured aortic smooth muscle to serum mitogens. J Cell Biol. 1981;89:379-383.
42. Manderson JA, Mosse PRL, Safstrom JA, Young SB, Campbell GR. Balloon catheter injury W rabbit carotid artery, I: changes in smooth muscle phenotype. Arteriosclerosis. 1989;9:289-298.
43. Holifield B, Helgason T, Jemelka S, Taylor A, Navran S, Allen J, Seidel C. Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest. 1996;97:814-825.
44. Seidel CL, Helgason T, Allen JC, Wilson C. Migratory abilities of different vascular cells from the tunica media of canine vessels. Am J Phvsiol. 1997;272:C847-C852.
45. Grunwald J, Haudenschild CC. Intimai injury in vivo activates vascular smooth muscle cell migration and explant outgrowth in vitro. Arteriosclerosis. 1984;4:183-188.
46. Pickering JG, Weir L, Rosenfield K, Stetz J, Jekanowski J, Isner JM Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology. J Am Coll Cardiol. 1992;20:1430-1439.
47. Schwartz SM, Foy L, Bowen-Pope DF, Ross R. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol. 1990;136:1417-1428.
48. Hultgardh-Nilsson A, Krondahl U. Querol-Ferrer V, Ringertz NR. Differences in growth factor response in smooth muscle cells isolated from adult and neonatal rat arteries. Differentiation. 1991;47:99-105.
49. Majack RA, Grieshaber NA, Cook CL, Weiser MCM, McFall RC, Grieshaber SS, Reidy MA, Reilly CF. Smooth muscle cells isolated from the neointima after vascular injury exhibited altered responses to platelet-derived growth factor and other stimuli. J Cell Physiol. 1996; 167:106-112.
50. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993;13: 1218-1226.
51. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor β. Biochim Biophys Acta. 1990;1032:79-87.
52. 1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb. 1991;11: 892-902.
53. Morisaki N, Kawano M, Koyama N, Koshikawa T, Umemiya K, Saito Y, Yoshida S. Effects of transforming growth factor-β, on growth of aortic smooth muscle cells: influences of interaction with growth factors, cell state, cell phenotype, and cell cycle. Atherosclerosis. 1991;88:227-234.
54. Assoian RK, Sporn MB. Type β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol. 1986;102:1217-1223.
55. 1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.
56. 1 expression, cellular proliferation and extracellular matrix expansion following arterial injury. Growth Factors. 1997;14: 297-306.
57. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986;83:4167-4171.
58. Funayama H, Ikeda U, Takahashi M, Sakata Y, Kitagawa S-I, Takahashi Y-I, Masuyama J-I, Furukawa Y, Miura Y, Kano S, Matsuda M, Shimada K. Human monocyte-endothelial cell interaction induces platelet-derived growth factor expression. Cardiovasc Res. 1998;37:216-224.
59. Majack RA, Majesky MW, Goodman LV. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J Cell Biol. 1990;111:239-247.
60. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB. Transforming growth factor type βinduces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A. 1987;84:5788-5792.
61. Pierce GS, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, Deuel TF. Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J Cell Biol. 1989;109:429-440.
62. Majack RA. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol. 1987;105:465-471.
63. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103-111.
64. Arciniegas E, Sutton AB, Allen TD, Schor AM. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci. 1992;103:521-529.
65. Kanzaki T, Tamura K, Takahashi K, Saito Y, Akikusa B, Oohashi H, Kasayuki N, Ueda M, Morisaki N. In vivo effect of TGF-β1: enhanced intimai thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol. 1995; 15:1951-1957.
66. Taubman MB, Marmur JD, Rosenfield C-L, Guha A, Nichtberger S, Nemerson Y. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. J Clin Invest. 1993;91:547-552.
67. Sprugel KH, McPherson JM, Clowes AW, Ross R. Effects of growth factors in vivo. I: cell ingrowth into porous subcutaneous chambers. Am J Pathol. 1987;129:601-613.
68. Pepper MS. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 1997: 8:21-43.
69. Flaumenhaft R, Rifkin DB. The extracellular regulation of growth factor action. MoL Cell Biol. 1992;3:1057-1065.
70. Nimni ME. Polypeptide growth factors: targeted delivery systems. Biomaterials. 1997;18:1201-1225.